Suppr超能文献

评估纳杰夫医院剖宫产术后血栓预防的现行实践并增强对指南的依从性。

Evaluating the Current Practice of Post Cesarean Thromboprophylaxis and Enhancing Guideline Adherence in Al-Najaf Hospitals.

机构信息

Department of Clinical Pharmacy, Pharmacy Sciences, Al-Sadr Medical City, Al-Najaf Health Directorate, Al Najaf Al-Ashraf, Iraq.

Faculty of Pharmacy, University of Kufa, Iraq.

出版信息

Med Arch. 2021 Oct;75(5):351-355. doi: 10.5455/medarh.2021.75.351-355.

Abstract

BACKGROUND

Venous thromboembolism (VTE) is one of the most common cardiovascular disorders in the United States and is manifested as deep vein thrombosis (DVT) and pulmonary embolism (PE) which represented as the most important cause of death in pregnant women after cesarean section. Venous thromboembolism (VTE) is representing the second direct cause of death which is accounting for 13.8% of all mother's death in the world. The most common risk factor of venous thromboembolism (VTE) is cesarean section.

OBJECTIVE

The study aims to study the current practice of post-cesarean thromboprophylaxis in dosing calculation and duration of therapy.

METHODS

Between September 2020 and January 2021, an observational- interventional prospective pre and post-study, was conducted in all hospital of Najaf in the City center and the suburbs that contain gynecology and obstetric ward to assess the current practice of post-cesarean thromboprophylaxis and to evaluate the impact of pharmacist intervention program to improve guideline adherence then after intervention. Another 102 patients were enrolled to analyze the change thromboprophylaxis according to the guideline.

RESULTS

From patient data, the rate of adherence to guidelines raised significantly among the post-intervention patients' group by thromboprophylaxis dose according to body weight was increase significantly (p<0.001) from 56.9% in the observation phase to 83.3% after intervention and about the duration of thromboprophylaxis is significantly (p<0.001) from 18.6% in the observation phase to 52.0% after the intervention.

CONCLUSION

This study showed that the clinical pharmacist's multifaceted intervention has resulted in encouraging guideline implementations as reflected by improving the proper use of thromboprophylaxis the duration anddosing calculations according to body weight.

摘要

背景

静脉血栓栓塞症(VTE)是美国最常见的心血管疾病之一,表现为深静脉血栓形成(DVT)和肺栓塞(PE),这是剖宫产后孕妇死亡的最重要原因。静脉血栓栓塞症(VTE)是第二大直接死因,占全球所有产妇死亡的 13.8%。静脉血栓栓塞症(VTE)最常见的危险因素是剖宫产。

目的

本研究旨在研究剖宫产术后血栓预防的剂量计算和治疗持续时间的现状。

方法

2020 年 9 月至 2021 年 1 月,在纳杰夫市中心和郊区的所有医院进行了一项观察性干预性前瞻性前后研究,评估了剖宫产术后血栓预防的现状,并评估了药师干预方案对提高指南依从性的影响,然后进行了干预。另外招募了 102 名患者,根据指南分析了血栓预防的变化。

结果

从患者数据来看,干预后患者组的指南依从率显著提高,根据体重计算的血栓预防剂量显著增加(p<0.001),从观察阶段的 56.9%增加到干预后的 83.3%,而血栓预防的持续时间也显著增加(p<0.001),从观察阶段的 18.6%增加到干预后的 52.0%。

结论

本研究表明,临床药师的多方面干预措施促使指南的实施得到了令人鼓舞的改进,体现在根据体重正确使用血栓预防药物的持续时间和剂量计算方面。

相似文献

2
Thromboprophylaxis following cesarean section - a nation-wide survey from Germany.
J Matern Fetal Neonatal Med. 2020 Jul;33(14):2359-2365. doi: 10.1080/14767058.2018.1550064. Epub 2019 Jan 3.
3
Safety and efficacy of thromboprophylaxis using enoxaparin sodium after cesarean section: A multi-center study in Japan.
Taiwan J Obstet Gynecol. 2015 Jun;54(3):248-52. doi: 10.1016/j.tjog.2014.09.008.
5
A multifaceted clinical decision support intervention to improve adherence to thromboprophylaxis guidelines.
Int J Clin Pharm. 2021 Oct;43(5):1327-1336. doi: 10.1007/s11096-021-01254-x. Epub 2021 Mar 11.
7
Enoxaparin administration within 24 hours of caesarean section: a 6-year single-centre experience and patient outcomes.
J Obstet Gynaecol. 2019 May;39(4):451-454. doi: 10.1080/01443615.2018.1527300. Epub 2018 Dec 22.
9
Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.
Thromb Res. 2014 Jan;133(1):25-9. doi: 10.1016/j.thromres.2013.09.011. Epub 2013 Sep 16.
10

本文引用的文献

1
A Pictorial Review of Postpartum Complications.
Radiographics. 2020 Nov-Dec;40(7):2117-2141. doi: 10.1148/rg.2020200031. Epub 2020 Oct 23.
2
Thromboprophylaxis following cesarean section - a nation-wide survey from Germany.
J Matern Fetal Neonatal Med. 2020 Jul;33(14):2359-2365. doi: 10.1080/14767058.2018.1550064. Epub 2019 Jan 3.
5
Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.
J Thromb Thrombolysis. 2016 Jan;41(1):92-128. doi: 10.1007/s11239-015-1309-0.
6
Epidemiology of venous thromboembolism.
Nat Rev Cardiol. 2015 Aug;12(8):464-74. doi: 10.1038/nrcardio.2015.83. Epub 2015 Jun 16.
7
Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: a multicenter survey.
J Crit Care. 2014 Jun;29(3):471.e1-9. doi: 10.1016/j.jcrc.2014.01.017. Epub 2014 Feb 5.
9
Awareness of patients who undergo cesarean section about venous thromboembolism prophylaxis.
J Vasc Nurs. 2013 Mar;31(1):15-20. doi: 10.1016/j.jvn.2012.07.001.
10
Improving adherence to best-practice guidelines for venous thromboembolism risk assessment and prevention.
Am J Health Syst Pharm. 2011 Nov 15;68(22):2184-9. doi: 10.2146/ajhp110102.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验